Sharmistha Pal

3.9k citations
40 papers · 2.9k indexed · h-index 22
Topics
Glioma Diagnosis and Treatment (9 papers)RNA modifications and cancer (9 papers)Epigenetics and DNA Methylation (7 papers)

In The Last Decade

Sharmistha Pal

39 papers receiving 2.8k citations

Peers

Sharmistha Pal
Comparison fields: 5 of 119
  • Molecular Biology 2.2k
  • Genetics 318
  • Cancer Research 305
  • Genetics 239
  • Oncology 224
Replace Sadhan Majumder with:
Sadhan Majumder United States
Anne Clavreul France
Einar Osland Vik-Mo Norway
Yang Xiao United States
Chunhui Di United States
Mark Duquette United States
Lingna Li United States
Masayuki Nitta Japan
Dongping He United States
Edroaldo Lummertz da Rocha United States
Sharmistha Pal relative to Sadhan Majumder United States Sadhan Majumder's profile →
Citations per field
00.5×1.5×
Sadhan Majumder · 1×
Citations per year

Countries citing papers authored by Sharmistha Pal

Since Specialization
Citations

This map shows the geographic impact of Sharmistha Pal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharmistha Pal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharmistha Pal more than expected).

Fields of papers citing papers by Sharmistha Pal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharmistha Pal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharmistha Pal. The network helps show where Sharmistha Pal may publish in the future.

Co-authorship network of co-authors of Sharmistha Pal

This figure shows the co-authorship network connecting the top 25 collaborators of Sharmistha Pal. A scholar is included among the top collaborators of Sharmistha Pal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharmistha Pal. Sharmistha Pal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 46
4 9
5 5
6 21
7 48
8 138
9 71
10 12
11 2
12 36
13 148
14 22
15 57
16 46
17 24
18 122
19 234
20 238

About Sharmistha Pal

Sharmistha Pal is a scholar working on Genetics, Cancer Research and Molecular Biology, having authored 40 papers that have together received 2.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (9 papers), RNA modifications and cancer (9 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Genetics (318 citations) and Cancer Research (305 citations). Sharmistha Pal has collaborated with scholars based in United States, India and Australia. Frequent co-authors include Saı̈d Sif, Paul Tempst, Hediye Erdjument‐Bromage, Ramana V. Davuluri, Li Wang, Ravi Gupta, Robert A. Baiocchi, Nadia Dahmane, Saikat Dutta and Yingtao Bi. Their work appears in journals such as Nucleic Acids Research, Nature Genetics and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026